Home » DERMISONICS FORMS SALES AND MARKETING ALLIANCE WITH PHARMAVENTURES
DERMISONICS FORMS SALES AND MARKETING ALLIANCE WITH PHARMAVENTURES
August 17, 2005
Dermisonics, Inc. (OTCBB:DMSI), a medical device company with its focus on the development of an ultrasonically assisted transdermal drug-delivery technology, announced today that its has formed a sales and marketing alliance with PharmaVentures Ltd (Oxford, UK) to promote its groundbreaking U-Strip transdermal drug-delivery device.
MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqWatqbKbmJi3yJyWnZq)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct